Biocompatibles moves forward with phosphorylcholine (PC) coating trials
This article was originally published in Clinica
Biocompatibles (UK) has completed human trials of its phosphorylcholine-coated coronary guidewires in the UK. The results, from a group of 50 patients have not yet been published, but Professor David Cumberland of the Northern General Hospital, Sheffield, says the results "are quite convincing and not yet quantified". He says the difference between coated and uncoated wires "is striking".
You may also be interested in...
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.